Perry Chavers

Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices

perrykchavers
Advertisements
  1. Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices  Bloomberg

    2.
  2. Novartis Bets $8.7 Billion on Gene-Therapy Company  Wall Street Journal
  3. Gene-therapy company with research ties to Columbus sold to Novartis for $8.7 billion  The Columbus Dispatch
  4. UPDATED: Novartis CEO Vas Narasimhan cuts loose an old anchor and sets sail with $8.7B AveXis buyout  Endpoints News

    5. Full coverage

from Business – Google News https://www.bloomberg.com/news/articles/2018-04-09/rare-diseases-command-mega-prices-with-novartis-wager-on-avexis

Advertisements

Advertisements